CONDENSED CONSOLIDATED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($) $ in Thousands	Total	Follow On Offering [Member]	At The Market Offering [Member]	Series A Convertible Preferred Stock	Series B Convertible Preferred Stock [Member]	IPO [Member]	Common Stock [Member]	Common Stock [Member] Follow On Offering [Member]	Common Stock [Member] At The Market Offering [Member]	Common Stock [Member] Class A Common Stock [Member]	Common Stock [Member] Class B Common Stock	Common Stock [Member] IPO [Member]	Subscription Receivable Preferred Stock Series A	Additional Paid In Capital	Additional Paid In Capital Follow On Offering [Member]	Additional Paid In Capital At The Market Offering [Member]	Additional Paid In Capital IPO [Member]	Accumulated Other Comprehensive (Income) Loss	Accumulated Deficit
Beginning balance at Dec. 31, 2022	$ (2,733)									$ 4				$ 112,436				$ 365	$ (115,538)
Beginning balance, shares at Dec. 31, 2022										60,417	856
Issuance of stock	4,452						$ 3							4,449
Issuance of stock, shares							216,923
Issuance of Common stock upon conversion of Common Stock							$ 4			$ (4)
Issuance of Common stock upon conversion of Common Stock, shares							60,417			(60,417)
Issuance of Common stock upon exercise of stock options	14													14
Common stock converted, shares							17,017				(17,017)
Issuance of Common stock upon exercise of stock options, shares											16,161
Stock-based compensation	15,057													15,057
Net exercise of options	323													323
Foreign currency translation loss	(115)																	(115)
Net Income (Loss)	(15,961)																		(15,961)
Ending balance at Mar. 31, 2023	1,037						$ 7							132,279				250	(131,499)
Ending balance, shares at Mar. 31, 2023							294,357
Beginning balance at Dec. 31, 2022	(2,733)									$ 4				112,436				365	(115,538)
Beginning balance, shares at Dec. 31, 2022										60,417	856
Foreign currency translation loss	(251)
Ending balance at Jun. 30, 2023	5,011						$ 7							149,991				114	(145,101)
Ending balance, shares at Jun. 30, 2023							354,463
Beginning balance at Mar. 31, 2023	1,037						$ 7							132,279				250	(131,499)
Beginning balance, shares at Mar. 31, 2023							294,357
Issuance of stock						$ 10,820											$ 10,820
Issuance of stock, shares												37,500
Initial Public Offering Costs	(4,607)													(4,607)
Issuance upon conversion of convertible notes, shares							14,129
Exercise of stock warrants (in shares)							8,477
Issuance of Common stock upon conversion of convertible notes	4,521													4,521
Exercise of stock warrants	2,468													2,468
Stock-based compensation	4,510													4,510
Foreign currency translation loss	(136)																	(136)
Net Income (Loss)	(13,602)																		(13,602)
Ending balance at Jun. 30, 2023	5,011						$ 7							149,991				114	(145,101)
Ending balance, shares at Jun. 30, 2023							354,463
Beginning balance at Dec. 31, 2023	(5,552)						$ 7							161,252				100	(166,911)
Beginning balance, shares at Dec. 31, 2023							354,802
Issuance of preferred stock Series A upon conversion of debt, Shares				3,430,895
Issuance of preferred stock Series A upon conversion of debt	10,082			$ 1										10,082
Subscription receivable for issuance of Series A preferred stock, shares				1,500,000
Subscription receivable for issuance of Series A preferred stock	(3,000)												$ (3,000)
Issuance of preferred stock series B upon acquisition of CLMBR, Inc, Shares					1,500,000
Issuance of preferred stock series B upon acquisition of CLMBR, Inc.					$ 2,688
Issuance of common stock upon acquisition of CLMBR, Inc, Shares							35,723
Issuance of common stock upon acquisition of CLMBR, Inc.	1,014						$ 0							1,014
Issuance of Common stock upon waiver to enter into Note Agreement							6,250
Issuance of Common stock upon waiver to enter into Note Agreement,Value	177						$ 0							177
Issuance of shares upon issuance of convertible notes, shares							18,750
Issuance of shares upon issuance of convertible notes	547						$ 0							547
Issuance of common stock from equity line of credit							32,777
Issuance of common stock from equity line of credit	692						$ 0							692
Issuance upon conversion of convertible notes, shares							37,149
Issuance of Common stock upon conversion of convertible notes	866						$ 0							866
Issuance of Common stock upon exercise of stock options, shares							394
Stock-based compensation	3,586													3,586
Foreign currency translation loss	39																	39
Net Income (Loss)	(11,394)																		(11,394)
Ending balance, shares at Mar. 31, 2024				4,930,895	1,500,000
Endng balance at Mar. 31, 2024				$ 1	$ 2,688
Ending balance at Mar. 31, 2024	(2,942)						$ 7						(3,000)	178,216				139	(178,305)
Ending balance, shares at Mar. 31, 2024							485,845
Beginning balance at Dec. 31, 2023	(5,552)						$ 7							161,252				100	(166,911)
Beginning balance, shares at Dec. 31, 2023							354,802
Foreign currency translation loss	37
Ending balance, shares at Jun. 30, 2024				6,868,865	1,500,000
Endng balance at Jun. 30, 2024				$ 1	$ 0
Ending balance at Jun. 30, 2024	413						$ 7							189,210				137	(188,942)
Ending balance, shares at Jun. 30, 2024							1,172,777
Beginning balance at Mar. 31, 2024	(2,942)						$ 7						(3,000)	178,216				139	(178,305)
Beginning balance, shares at Mar. 31, 2024							485,845
Issuance of stock		$ 809	$ 405					$ 0	$ 0						$ 809	$ 405
Issuance of stock, shares								142,046	162,378
Registered direct offering costs	(74)													(74)
At the Market offering costs	(50)													(50)
Issuance of preferred stock Series A upon conversion of debt, Shares				1,562,970
Issuance of preferred stock Series A upon conversion of debt	2,368			$ 0										2,368
Subscription receivable for issuance of Series A preferred stock	3,000												$ 3,000
Issuance of common stock from equity line of credit							7,918
Issuance of common stock from equity line of credit	65						$ 0							65
Issuance upon conversion of convertible notes, shares							251,084
Exercise of stock warrants (in shares)							23,112
Issuance of Common stock upon conversion of convertible notes	1,084						$ 0							1,084
Issuance of Common stock upon conversion of warrants, Shares				375,000
Issuance of Common stock upon conversion of warrants	480			$ 0										480
Reclassification of series B preferred stock to permanent equity, Shares					(1,500,000)
Reclassification of series B preferred stock to permanent equity					$ (2,688)
Reclassification of series B preferred stock to permanent equity, Shares					1,500,000
Reclassification of series B preferred stock to permanent equity	2,955				$ 0									2,955
1 for 40 reverse stock split share round up							100,312
Exercise of stock warrants	92						$ 0							92
Issuance of Common stock upon exercise of stock options, shares							82
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture							0
Stock-based compensation	2,860													2,860
Foreign currency translation loss	(2)																	(2)
Net Income (Loss)	(10,637)																		(10,637)
Ending balance, shares at Jun. 30, 2024				6,868,865	1,500,000
Endng balance at Jun. 30, 2024				$ 1	$ 0
Ending balance at Jun. 30, 2024	$ 413						$ 7							$ 189,210				$ 137	$ (188,942)
Ending balance, shares at Jun. 30, 2024							1,172,777